chrisvoncsefalvay/vaers-outcomes huggingface dataset:
An adult patient received a pediatric dose of VAQTA; An adult patient received a pediatric dose of VAQTA; No known adverse effects; This spontaneous report was received from a nurse, concerning an adult patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not reported.  On an unknown date, the patient was vaccinated with a pediatric dose of Hepatitis A Vaccine, Inactivated (VAQTA) (dose and route of administration were not reported, lot number R030115 has been verified to be a valid lot number, and expiration date: 29-DEC-2019), indicated for prophylaxis (incorrect dose administered and underdose). No adverse effects were known.  This is one of 2 reports received from the same reporter.; Sender's Comments:  US-009507513-1910USA005274:
Got the vaccine on 8/17.  Had expected reaction on 8/18 with chills and body ache.  Worsened on 8/19 with a UTI.  Never had fever.
In Jan 2023 I started experiencing a constant humming sound in my left ear. I visited an ENT and had a audiometry exam. It was confirmed that I have a significant amount of hearing loss in my left ear specifically high pitches. I was diagnosed with Tinnitus and have a follow up scheduled with an Audiology specialist.
faint, cold/clammy, and sweating.; dizziness; blood pressure changes; chills; fatigue that would come and go; severe itching on both her forearms.; lips on the inside of her mouth swelled up on one side; This spontaneous case was reported by a consumer and describes the occurrence of MOUTH SWELLING (lips on the inside of her mouth swelled up on one side), PRURITUS (severe itching on both her forearms.), FATIGUE (fatigue that would come and go), CHILLS (chills) and DIZZINESS (dizziness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MOUTH SWELLING (lips on the inside of her mouth swelled up on one side). On 22-Jan-2021, the patient experienced PRURITUS (severe itching on both her forearms.). On 23-Jan-2021, the patient experienced FATIGUE (fatigue that would come and go). On 31-Jan-2021, the patient experienced CHILLS (chills). On 02-Feb-2021, the patient experienced DIZZINESS (dizziness) and BLOOD PRESSURE ABNORMAL (blood pressure changes). On an unknown date, the patient experienced NASOPHARYNGITIS (faint, cold/clammy, and sweating.). The patient was treated with CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ZYRTEC PLUS) for Itching, at an unspecified dose and frequency. At the time of the report, MOUTH SWELLING (lips on the inside of her mouth swelled up on one side), PRURITUS (severe itching on both her forearms.), FATIGUE (fatigue that would come and go), CHILLS (chills), DIZZINESS (dizziness), BLOOD PRESSURE ABNORMAL (blood pressure changes) and NASOPHARYNGITIS (faint, cold/clammy, and sweating.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Blood pressure measurement: 61/45, 71/49, 107/64, 109/65, 82/53, 71/53.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient appeared with red, raised, itching rash around injection site. She said it itched the day of the injection & the following day she looked at it & there was rash. Cold compress & BENADRYL suggested.
pt recv vax 9FEB98 & on the evening of 9FEB98 pt became very irritable & jittery;mom took pt to ER;back to ER 20FEB98 for blood work, urine test; spinal tap;blood & spinal tap negative;urine pending;
muscle pain to deltoid, suprascapular, axilla & pectoral region;medrol dose pak, vicodin for pain;
Palpitations that started 2 days after vaccine, occurring daily and lasted for 3 weeks.
Patient experienced extreme fatigue and increase seizure frequency, and a new type of generalized seizures. This began 2 days after the injection, worsened, and then resolved by day 16. Rescue medication (ativan) was used at home on 3 occasions. Patient had a video visit with neurologist, who ordered tests thatr returned mostly nirmal votes (elevated whites consistent with immune response to vaccination). Prior to this, patient had been mostly seizure-free since October 2020.
Pt recvd flu vax & 19NOV93 later that day pt exp muscle aches, h/a & abdo pain; 3 days later was dizzy;
Information has been received from a nurse concerning a female patient who was vaccinated with a first and second dose of Gardasil. Concomitant therapy included ADVIL. The nurse reported that the patient had flushing around her ears throughout her body shortly after the first injection. After the second dose of Gardasil, she noticed spells of being hot and cold and had a fever and thought it was a urinary tract infection. Unspecified medical attention was sought by the patients. The patient recovered. Additional information has been requested.
persistent soreness; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The age group was selected as an adult, however it was selected as an adult as per vaccine indication. The reporter reported persistent soreness from Shingrix vaccination.
On 10/17/21, I went to urgent care due to chest pain.  EKG was abnormal.  I was taken to hospital.  I was diagnosed with myocarditis and released the next day.  All testing was negative for COVID.  The official diagnosis was for myocarditis caused by a virus - It wasn't linked to either Covid or the vaccine, but I thought it was worth reporting this.
Pt. fully vaccinated with Pfizer - dose 1 12/30/2020 and dose 2 on 1/20/2021.  Pt. reports a high risk community exposure to a COVID positive household member starting 9/1/21 and pt. was unable to separate from +HHM.  Pt. reports their own COVID symptoms of sore throat, cough, headache, loss of taste and loss of smell starting 9/2/21. Pt. tested COVID positive on 9/9/21.
Large 10 x 10 cm area erythema (R) deltoid central clearing.
Cellulitis that began in left elbow and spread to hand, forearm and upper arm. Onset was on Monday, March 15th around 1:45 am. No breaks in skin were present.
Sudden profound sensorineural hearing loss in right ear.  Woke up with no hearing in right ear.  Seen by ENT that day, course of oral steroids unsuccessful, three intratympanic injections unsuccessful.  Hearing aids now in place.
Soon after receiving the vaccine client passed out. Denies difficulty breathing, denies  swelling of tongue or throat, or chest pain. Just breathing heavy.
Rash Information has been received from a registered nurse concerning a 5 year old female who on approximately 06-APR-2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  subsequently, the patient experienced a generalized rash.  Medical attention was sought.
Left deltoid swollen, redness, warm to the touch. Patient treated for cellulitis prescribed Keflex 500 mg four times a day and Motrin 600 mg for pain.
Itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itchy rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH PRURITIC (Itchy rash). At the time of the report, RASH PRURITIC (Itchy rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Administered at approx 1415. 1500 small tickle in back of throat by 1700 it was difficult to swallow and I was unable to take a deep breath without choking/coughing. Felt like someone was holding my throat whenever I swallowed.
BREAKTHROUGH COVID: FULLY VACCINATEDAND BOOSTED WITH PFIZER. PT FOUND TO BE DCOVID-19 POSTIVE,  AND HAS A HISTORY OF COVID +. PT admitted with shortness of breath, cough, aspiration pneumonia- choking episode prior to admission, and ESBL Klebsiella pneumoniae UTI. Prior to discharge pt was tested positive for COVID 19. Infectious disease did not medicate for COVID 19.
Patient is a 58 years old female sent to ER for evaluation.  Patient received COVID-19 immunizations.  Second dose Pfizer . mRNA. around 10:25 AM today.  Patient is complaining of dyspnea at rest, dizziness and chest discomfort tightness.  Patient stated that with first dose she developed fever , nausea vomiting and dyspnea. Patient has history of hyperlipidemia.  No coronary disease.  Patient has history of COVID-19 infection in July 2020. Diagnosed with RESIDUAL  pulmonary fibrosis. No skin rash.  No nausea.  No vomiting no abdominal.  No sensation throat closing, no wheezing, no cough No hypotension at ER arrival No hives.  No itching, no swelling of face or lips. Patient denies history anxiety or depression.  No history of coronary disease.  No history of hypertensio
Night sweats; couldn't sleep; really tired; severe headache; body aches and pain; Fever; sweaty; feels super cold; feels bad; she was unable to move; This is a spontaneous report from a contactable consumer (patient).  A 30-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER2613, age at vaccination 30 years), via an unspecified route of administration, administered in Arm Left on 23Mar2021 as DOSE 2, SINGLE for Covid protection. The patient medical history was not reported. Concomitant medications included colecalciferol (VITAMIN D [COLECALCIFEROL]) taken for vitamin d decreased at a dose of 10,000 units weekly, from an unspecified start date and ongoing (has been taking for maybe 6 months); hydrocodone at a dose of 10mg twice daily taken for pain and back problems, start and stop date were not reported (has been taking for a couple of years for back problems). The patient previously took first dose of bnt162b2 (Lot: EN6205) via an unspecified route of administration, administered in arm on 02Mar2021 as DOSE 1, SINGLE for covid-19 immunisation and received a Vitamin b12 injection the day before in the same arm. The patient experienced severe headache, body aches and pain, fever, couldn't sleep, really tired on 23Mar2021, night sweats on 24Mar2021, sweaty, feels super cold, feels bad, she was unable to move on an unspecified date in 2021. It was reported that, the patient received the vaccine and was having bad reactions. She wanted to see if this was normal and why her body was acting like this. She had a severe headache, body aches and pain that was like being beat so hard all over, fever and night sweats, sweaty and cold really bad, could not sleep, was really tired, started feeling most of these last night, reporter still felt bad this morning. Took Children's Tylenol because her fever was going up, also taken some Aleve. Did not have a fever right now, but she felt super cold and sweaty, fever went down and was unable to move. Therapeutic measures taken as a result of the events included Children's Tylenol (Children's Tylenol liquid acetaminophen. Confirmed the brand name. Strength 160mg/5ml, Lot: SFM002, Expiry May2022) because her fever was going up. She also took some Aleve. No AE(s) required a visit to: Emergency Room, physician Office. The outcome of the events of headache and fever was recovering, the outcome of rest of the events was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
after his first Moderna Covid-19 vaccine last year in 2021,he developed a few of the plaque spot; This spontaneous case was reported by a consumer and describes the occurrence of SKIN PLAQUE (after his first Moderna Covid-19 vaccine last year in 2021,he developed a few of the plaque spot) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hip replacement.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced SKIN PLAQUE (after his first Moderna Covid-19 vaccine last year in 2021,he developed a few of the plaque spot). At the time of the report, SKIN PLAQUE (after his first Moderna Covid-19 vaccine last year in 2021,he developed a few of the plaque spot) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant product reported by reporter. No treatment medication reported by reporter.   This case was linked to MOD-2022-597447 (Patient Link).
c/o numbness left hand, states happened after 1st shot but was several hours later, declines Benadryl, states makes her drowsy, states she will just monitor herself and return if it gets worse.
2 inches of red circle around the injection site; it has been hot; around the injection site has been sore; around the injection site has been swollen; around the injection site has been itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (2 inches of red circle around the injection site), INJECTION SITE WARMTH (it has been hot), INJECTION SITE PAIN (around the injection site has been sore), INJECTION SITE SWELLING (around the injection site has been swollen) and INJECTION SITE PRURITUS (around the injection site has been itchy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (2 inches of red circle around the injection site), INJECTION SITE WARMTH (it has been hot), INJECTION SITE PAIN (around the injection site has been sore), INJECTION SITE SWELLING (around the injection site has been swollen) and INJECTION SITE PRURITUS (around the injection site has been itchy). The patient was treated with LORATADINE (CLARITINE) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, INJECTION SITE ERYTHEMA (2 inches of red circle around the injection site), INJECTION SITE WARMTH (it has been hot), INJECTION SITE PAIN (around the injection site has been sore), INJECTION SITE SWELLING (around the injection site has been swollen) and INJECTION SITE PRURITUS (around the injection site has been itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow up received
MD rpt pt recv 1dose of varivax 6/19/97 & in 5/98 pt devel 10-20 pox that was itchy rash, MD dx w/coxsackie virus
This spontaneous report as received from a healthcare worker refers to a patient of unknown age. On 14-MAY-2013 the patient was vaccinated with a dose of VAQTA 50/1.0 U/ML lot # 0628AE, expiration 26-JAN-2015 and a dose of RECOMBIVAX HB lot # reported as 0231AA, expiration 02-NOV-2014 (dose and route unknown for both vaccines). The Healthcare worker reported that VAQTA and RECOMBIVAX HB had multiple excursions from 20-FEB-2013 to 13-MAY-2013. The lowest temperature the vaccines reached was 24F. The total time of hours for the excursions was 253 hours. No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Within minutes of the injection in my left upper arm, I noticed my fingers on my left hand were not functioning fully, kind of like trying to use your fingers after your hand has fallen asleep and is almost "awake" but not quite.  About an hour later, I started noticing it hurt my arm socket to move my arm certain ways. Over the remainder of the night, it became increasingly worse, causing a sharp pain in the socket when I would move my arm at all, to the point where it was excruciating to try to undress for bed. At times, there was also a numbness or tingling that would go down my entire arm into my fingers, similar to what you feel after hitting your funny bone really hard.  I was only able to sleep lying on my back...any other position was too painful in the socket.  Today, the numbness and tingling in the arm and fingers has stopped, but the socket still has sharp pain to the extent that I've been keeping my arm stable against my body as much as possible (I feel no pain if I do that).
no adverse event; patient accidently received a dose of either MMRlI or VARIVAX mixed with a non Merck diluent/ the diluent used was for SHINGREX; This spontaneous report was received from a registered nurse and refers to a 32-year-old patient of an unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was not provided.  On 23-DEC-2020, the patient was accidently vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 milliliter (route of administration, anatomical localization, lot # and expiration date were unknown) for prophylaxis or with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) 0.5 ml (route of administration, anatomical localization, lot # and expiration date were unknown) for prophylaxis, that was reconstituted with a sterile diluent for zoster rgE vaccine (mammalian) (SHINGRIX) (reported as SHINGREX, non-Merck diluent), also reported as so 1b mono phospholipid lipid a qs-21 natural compound extracted from the soap bark tree combined in liposomal formulation (dose, route of administration, lot # and expiration date were unspecified). The patient did not complain of any adverse reactions. The reporter was unsure of the exact patient that received the incorrectly prepared measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) or varicella virus vaccine live (oka/merck) (VARIVAX).  This is one of two case reports from the same reporter.; Sender's Comments:  US-009507513-2101USA001854:
4 days after admin - diffuse trunk papular rash - no vesicle no itchy; pt opted for antihistamine Rx alone - no steroids.
Initial report received from a health care professional on 18 January 2011. A 6 month-old male patient with no known allergies, and current medical condition of GERD for which he takes ZANTAC, had received on 20 December 2010 a first left thigh dose of FLUZONE (lot number UT3619AA), and a dose of PENTACEL, HEP B (manufacturer unknown), PREVNAR (Wyeth) and ROTATEQ (Merck), lot numbers not reported. At the end of the week of January 14 2011, the patient was diagnosed with Influenza B. The patient required a physician visit, however treatments received were not reported. Recovery status was not reported. Documents held by sender: None.
This report describes the occurrence of a possible seizure in a 14 year old male who received hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received from the pt's mother and has not been verified by a physician or other healthcare professional. The mother stated that in 1999, the pt received his first dose of hep B vaccine. Reportedly, at an unspecified time post-immunization, he experienced "a more severe reaction than the reaction to the second dose." In the afternoon of 8/5/03, the subject received his second dose of Engerix B. According to the mother, the pt experienced "shaking and uncomfortable, strong" and loss of taste approximately 45 mins post-immunization. She stated that a "possible seizure" occurred during the evening of 8/5/03. Reportedly, the pt was taken to the local ER, where he was treated with unspecified IV medication "because he had not eaten all day" and Atarax. The mother stated that the pt was monitored and then sent home on the same day. Reportedly, the pt was "emotionally and socially drained after this event and does not have any memory of the experience." The seizure resolved on 8/5/03. The shaking, uncomfortable feeling, loss of taste, and feeling of being emotionally and socially drained resolved after approximately one week. The Engerix B immunization series was discontinued. Possible seizure is considered to be medically serious by manufacturer (OMIC).
Treatment of the adverse event is ongoing and the physicians are not sure it is related to shingrix but they think it is a possibility. Symtpoms have been weakness , shortness of breath, joint pain, could not walk, dizziness, rash, bladder stopped functioning, numbness on feet and legs.
Following vaccination for MCV4 and HPV, patient fainted and MA reports convlusions as well. Came to quickly within seconds and expressed not feeling well. Breathing normally and crying.Then patient vomited.   Mom reports he has had a prior, similar reaction to getting an injection when he's had surgery in the past.  Advised Urgent Care for observation and possible labs. Mom prefers not to wait at this time as 2 of her other kids are also with her and she needs to take them to school.   Vitals retaken with normal 02 sat and BP unchanged from reading prior to the episode. Patient feels very tired and somewhat disoriented.   Upon further reflection mom would like further evaluation/observation at Urgent Care today.   Report called to Urgent Care and patient taken down by wheelchair.
Soreness and redness first couple of days, that disappeared.  Day 9 began as a red 3 inch circumference circle that gradually has been growing in size and spreading, now about 7" length and 4" width, outer edges deep red, inner area light red.  Not painful, minimal swelling.  No restriction in arm movement, normal temperature.
pt recvd vax & devel sore throat, severe h/a, chills, fever, all over body aches (severe pain), dizziness, nausea, lightheadedness, diarrhea;got flu shot on 25OCT 1030AM felt fine the rest of day;3AM 26OCT95 awoke coughing w/full-blown cold
NauseaVomiting, HYPERtension & Tachycardia Approx 15 mins after injection employee reported nausea was found to be tachycardia and hypertensive.
I got my J&J covid shot back in May last year and I experience a little discomfort for the first month. Then it went away. Then beginning in Sept, I started to get sharp pains in the shoulder joint itself where the ball and socket meet. I could be sitting still with no movement in the joint and all of a sudden, my body would have to jerk in a certain direction because of the pain.
Extensive lower abdomen and bilateral leg rash developed on 5/10/21 after pt received his 2nd dose of Moderna COVID 19 vaccine on 4/27/21.  I can send pictures of the rash